Hikma Pharmaceuticals PLC (HIK.L) LSE

1,699.00

-21(-1.22%)

Updated at September 08 06:13PM

Currency In GBp

Valuation

Market Cap5.59B
Enterprise Value6.7B
P/E Ratio14.23
PEG Ratio0.53
Price/Sales Ratio1.63
Price/Book Ratio2.21
Enterprise/Revenue1.99
Enterprise/EBITDA7.9

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.11
Operating Margin0.2

Management Effectiveness

Return On Assets0.07
Return On Equity0.16

Income Statement

Revenue3.13B
Revenue/Share14.1
Gross Profit1.42B
EBITDA787M
Net Income359M
Diluted EPS1.61

Balance Sheet

Total Cash213M
Total Cash/Share0.96
Total Debt1.31B
Total Debt/Equity0.57
Current Ratio1.14
Book Value Per Share10.46

Price History

52-Week Change-12.6
52-Week High2,360
52-Week Low1,686
Moving Average 50 Days1,893.96
Moving Average 200 Days2,015.25

Statistics

Average Volume534,093
Shares Outstanding220.43M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0.64
Trailing Annual Dividend Yield3.74
Payout Ratio0.49
Last Split Factor1:1
Last Split DateSeptember 04, 2013